Save up -80% on Fluticasone furoate
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Veramyst
|$195.16||1 nasal spray (10g) 27.5mcg|
|price without discount in nearest pharmacy. Price may vary.|
We offer free Fluticasone furoate coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Fluticasone furoate every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Fluticasone furoate volume of distribution
A large volume of distribution results in a long elimination half-life as can be seen for fluticasone propionate (t1/2 = 7–8 hours) (10, 57, 62, 64, 65). Mometasone fuorate also has a long elimination half-life after intravenous administration; it is reported to be 5.8 hours (23).
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Fluticasone furoate
Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. Despite the similarity in the names, fluticasone furoate and fluticasone propionate are different drugs with different properties. It is marketed under the brand name, Veramyst in the US by GlaxoSmithKline for the management of chronic obstructive pulmonary disease (COPD). FDA approved on April 27, 2007. Fluticasone furoate is available as a combination product with vilanterol, a long-acting beta-2 agonist, under the tradename Breo Ellipta. Approved by the FDA in 2013, its use is indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It is also indicated for once-daily maintenance treatment of asthma in patients aged 18 or older with reversible obstructive airways disease.
Fluticasone furoate mechanism of action
Fluticasone furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. The precise mechanism through which fluticasone furoate affects rhinitis symptoms is not known. Corticosteroids have been shown to have a wide range of actions on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) involved in inflammation. Specific effects of fluticasone furoate demonstrated in in vitro and in vivo models included activation of the glucocorticoid response element, inhibition of pro-inflammatory transcription factors such as NFkB, and inhibition of antigen-induced lung eosinophilia in sensitized rats. Fluticasone is also found to increase airway retention of long-acting beta adrenergic agonist, thus potentiating its beneficial effects for the treatment of asthma.
Dosage forms of Fluticasone furoate
|Veramyst Nasal Spray||27.5mcg||120doses Nasal Spray||$41.00|
|Arnuity Ellipta||100mcg||30doses Powder for Inhalation||$122.00|
|Arnuity Ellipta||200mcg||30doses Powder for Inhalation||$163.00|
|Breo Ellipta||92/22mcg||30doses Powder Inhaler||$147.00|
|Trelegy Ellipta||92/55/22mcg||30 doses Inhalation Powder||$133.00|
Fluticasonum furoas Furoate de fluticasone
Humans and other mammals
Indication of Fluticasone furoate
Fluticasone furoate nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older. Breo Ellipta, a mixture of fluticasone furoate and vilanterol is indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. It is also indicated for once-daily maintenance treatment of asthma in patients aged 18 or older with reversible obstructive airways disease. Breo Ellipta should not be used for the relief of acute symptoms of asthma or COPD.
Toxicity of Fluticasone furoate
The most common adverse reactions (1% incidence) included headache, epistaxis, pharyngolaryngeal pain, nasal ulceration, back pain, pyrexia, and cough.
RX24 Drugs Disclaimer: before buying a Fluticasone furoate on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.
Get lower price on Fluticasone furoate now!
What is a Veramyst?
Veramyst is a nasal spray containing fluticasone. This prevents the release of substances in the body that cause inflammation. Veramyst nasal spray is used to treat nasal congestion, sneezing, runny nose and itchy or watery eyes caused by seasonal or year-round allergies.
Before using Veramyst, tell your doctor if you have glaucoma or cataracts, liver disease, diabetes, herpes simplex viruses in the eyes, tuberculosis or any other infection, ulcers or ulcers inside your nose, or if you have recently had injuries or operations on your nose. It may take up to several days to use Veramyst nasal spray before your symptoms improve. Tell your doctor if your symptoms do not improve after a week of treatment.
Veramyst can reduce blood cells that help your body fight infections. Avoid being near sick people or having infections. Call your doctor for preventive treatment if you are exposed to chicken pox or measles. These conditions can be serious or even fatal for people who use Veramyst.
Throw away a bottle of Veramyst after you have used 120 sprays, even if there is medicine left in the bottle. Do not give Veramyst to a child under 2 years of age without consulting a doctor. Steroid drugs can affect growth in children. Talk to your doctor if you think your child is not growing at a normal rate when using Veramyst. Follow all directions on label and package. Tell each of your health care providers about all your medical conditions, allergies, and all medications you use.
What is Breo Ellipta?
Breo Ellipta Inhalation Powder contains a combination of fluticasone and Vilanterol. Fluticasone is a steroid. This prevents the release of substances in the body that cause inflammation. Vilanterol is a bronchodilator. It works by relaxing the muscles in the airways to improve breathing.
Breo Ellipta is a single-use combination medicine used in adults with asthma or COPD (chronic obstructive pulmonary disease) to improve symptoms and prevent bronchospasm or asthma attacks.
In people with COPD, Breo Ellipta is intended for long-term treatment. In people with asthma, this medicine is intended for short-term treatment until the symptoms are well controlled with other medicines. Vilanterol may increase the risk of death in people with asthma, but the risk in people with COPD is unknown. Talk to your doctor about your individual risks and the benefits of using this medication.
You should not use Breo Ellipta if you are allergic to fluticasone, vilanterol or milk proteins. Breo Ellipt is not a life-saving medicine. It will not work fast enough to treat asthma or bronchospasm. Vilanterol may increase the risk of death in people with asthma, but the risk in people with COPD is unknown.